California State Teachers Retirement System Has $817.30 Million Stock Holdings in Teleflex Incorporated $TFX

Key Points

• California State Teachers Retirement System increased its Teleflex stake by 12,426.5% to 6.45 million shares, valued at approximately $817.3 million and representing 15.22% of the company. Institutional investors collectively own 95.62% of Teleflex.
• Analyst sentiment is mixed, with one Strong Buy, four Buys, six Holds and one Sell; the consensus rating is Hold with an average price target of $152.90, compared with the stock’s reported price of $130.85.
• Teleflex reported quarterly EPS of $1.76 versus the $1.28 consensus estimate, while revenue rose 28.9% year over year to $570.33 million. The company also declared a quarterly dividend of $0.34, equivalent to a $1.36 annualized payout and a 1.0% yield.

California State Teachers Retirement System increased its holdings in Teleflex Incorporated (NYSE:TFX - Free Report) by 12,426.5% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,447,647 shares of the medical technology company's stock after acquiring an additional 6,396,175 shares during the period. California State Teachers Retirement System owned about 15.22% of Teleflex worth $817,304,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in TFX. BlackRock Inc. purchased a new stake in Teleflex in the 2nd quarter valued at about $688,537,000. Jupiter Topco LLC purchased a new position in Teleflex in the second quarter worth $550,456,000. Janus Henderson Group PLC boosted its position in Teleflex by 1.1% in the first quarter. Janus Henderson Group PLC now owns 4,291,311 shares of the medical technology company's stock worth $513,281,000 after purchasing an additional 45,199 shares during the last quarter. AQR Capital Management LLC grew its stake in Teleflex by 478.1% in the 3rd quarter. AQR Capital Management LLC now owns 2,366,131 shares of the medical technology company's stock valued at $287,603,000 after purchasing an additional 1,956,811 shares during the period. Finally, State Street Corp grew its stake in Teleflex by 1.5% in the 4th quarter. State Street Corp now owns 1,478,776 shares of the medical technology company's stock valued at $180,470,000 after purchasing an additional 22,111 shares during the period. Institutional investors own 95.62% of the company's stock.

Analyst Upgrades and Downgrades

Several analysts have commented on the stock. Truist Financial lifted their price objective on shares of Teleflex from $143.00 to $150.00 and gave the stock a "hold" rating in a research report on Monday, August 10th. BMO Capital Markets started coverage on shares of Teleflex in a research note on Wednesday, July 8th. They set an "outperform" rating and a $159.00 price target for the company. Piper Sandler reaffirmed an "overweight" rating and issued a $169.00 price target (up from $160.00) on shares of Teleflex in a report on Friday, August 7th. UBS Group upped their price objective on Teleflex from $145.00 to $158.00 and gave the company a "neutral" rating in a research note on Tuesday, August 11th. Finally, Weiss Ratings reissued a "sell (d)" rating on shares of Teleflex in a report on Wednesday, June 24th. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and an average target price of $152.90.

Teleflex Stock Down 0.1%

Shares of TFX opened at $130.85 on Monday. The company has a debt-to-equity ratio of 0.94, a current ratio of 2.60 and a quick ratio of 2.12. Teleflex Incorporated has a 1 year low of $100.18 and a 1 year high of $145.00. The stock has a 50 day simple moving average of $135.72 and a two-hundred day simple moving average of $128.10. The firm has a market cap of $5.54 billion, a P/E ratio of -5.62, a P/E/G ratio of 0.87 and a beta of 0.82.

Teleflex (NYSE:TFX - Get Free Report) last posted its quarterly earnings results on Thursday, August 6th. The medical technology company reported $1.76 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.28 by $0.48. The business had revenue of $570.33 million for the quarter, compared to analyst estimates of $559.59 million. Teleflex had a positive return on equity of 11.93% and a negative net margin of 39.67%.Teleflex's revenue for the quarter was up 28.9% compared to the same quarter last year. During the same period last year, the company earned $3.73 EPS. Teleflex has set its FY 2026 guidance at 6.900-7.200 EPS. On average, analysts forecast that Teleflex Incorporated will post 7.26 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Friday, August 14th will be given a $0.34 dividend. The ex-dividend date of this dividend is Friday, August 14th. This represents a $1.36 annualized dividend and a dividend yield of 1.0%. Teleflex's dividend payout ratio is currently -5.84%.

Teleflex Profile

Teleflex Incorporated is a global medical technology company that develops, manufactures and supplies specialty medical devices for hospitals, clinicians and other health care providers. Its products are designed to support procedures in areas including vascular access, interventional cardiology and radiology, anesthesia, emergency medicine, surgery and urology.

The company's portfolio includes Arrow branded vascular access and catheter products, airway management devices, regional anesthesia products, surgical instruments, interventional devices and urological products.

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.